The rising cancer crisis in year two of COVID-19

The fear of exposure to Covid-19 coupled with the temporary shutdown of non-emergency health services put millions of people off routine healthcare screenings. Now, in the second year of the pandemic, a wave of cancer diagnoses is revealing a new crisis.

That’s the scene painted by ProPublica in a recent report about some of the cancer patients receiving late-stage diagnoses as a result of delays in routine care during the pandemic. It’s been well documented that cancer screenings and other care services dropped off steeply during the beginning months of the pandemic. Many physician offices closed or stopped seeing patients in person altogether for a period of time. Adults delayed care, while many parents put off care for their children, as well.

Preventive cancer screenings dropped 94% in the first four months of 2020, according to ProPublica.

“Amid the damage is an untold number of cancers that went undiagnosed or untreated as patients postponed annual screenings, and as cancer clinics and hospitals suspended biopsies and chemotherapy and radiation treatments,” ProPublica reported. 

And the damage is expected to come in an excess of 100,000 cancer deaths over the next decade, according to the National Cancer Institute.

See the full story below:

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.